{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:26:38Z","timestamp":1792293998411,"version":"4.4.0"},"reference-count":140,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/grf.0b013e31824b4611","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T03:09:28Z","timestamp":1329534568000},"page":"3-23","source":"Crossref","is-referenced-by-count":255,"title":["Ovarian Cancer"],"prefix":"10.1097","volume":"55","author":[{"given":"JESSICA","family":"HUNN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUSTAVO C.","family":"RODRIGUEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-3-20210126","first-page":"20","article-title":"Prevention of ovarian cancer: intraepithelial neoplasia.","volume":"9","author":"Brewer","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R4-3-20210126","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jnci\/94.1.50","article-title":"Progestin-induced apoptosis in the macaque ovarian epithelium: differential regulation of transforming growth factor-beta.","volume":"94","author":"Rodriguez","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"suppl","key":"R5-3-20210126","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jcb.240590928","article-title":"Pathology of ovarian cancer precursors.","volume":"23","author":"Scully","year":"1995","journal-title":"J Cell Biochem"},{"key":"R6-3-20210126","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/cncr.11847","article-title":"Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.","volume":"98","author":"Roland","year":"2003","journal-title":"Cancer"},{"key":"R7-3-20210126","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1002\/cncr.10497","article-title":"Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.","volume":"94","author":"Yang","year":"2002","journal-title":"Cancer"},{"key":"R8-3-20210126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0090-8258(90)90075-V","article-title":"Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma.","volume":"38","author":"Plaxe","year":"1990","journal-title":"Gynecol Oncol"},{"key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R10-3-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.pap.0000201826.46978.e5","article-title":"Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer.","volume":"13","author":"Lee","year":"2006","journal-title":"Adv Anat Pathol"},{"key":"R11-3-20210126","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ajog.2004.02.067","article-title":"Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.","volume":"191","author":"Piek","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R12-3-20210126","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R13-3-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"R15-3-20210126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship.","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA12 mutation carriers.","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"R18-3-20210126","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/89.13.932","article-title":"Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.","volume":"89","author":"Schildkraut","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R19-3-20210126","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1126\/science.2136249","article-title":"Too many rodent carcinogens: mitogenesis increases mutagenesis.","volume":"249","author":"Ames","year":"1990","journal-title":"Science"},{"key":"R20-3-20210126","first-page":"7415","article-title":"Increased cell division as a cause of human cancer.","volume":"50","author":"Preston-Martin","year":"1990","journal-title":"Cancer Res"},{"key":"R21-3-20210126","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/oxfordjournals.aje.a116429","article-title":"Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group.","volume":"136","author":"Whittemore","year":"1992","journal-title":"Am J Epidemiol"},{"key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/oxfordjournals.aje.a113523","article-title":"Events of reproductive life and the incidence of epithelial ovarian cancer.","volume":"117","author":"Risch","year":"1983","journal-title":"Am J Epidemiol"},{"key":"R24-3-20210126","first-page":"711","article-title":"Determinants of ovarian cancer risk. I. Reproductive experiences and family history.","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/oxfordjournals.aje.a121603","article-title":"An epidemiologic study of the relationship of reproductive experience to cancer of the ovary.","volume":"99","author":"Joly","year":"1974","journal-title":"Am J Epidemiol"},{"key":"R26-3-20210126","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/oxfordjournals.aje.a113207","article-title":"An epidemiologic study of epithelial carcinoma of the ovary.","volume":"114","author":"Hildreth","year":"1981","journal-title":"Am J Epidemiol"},{"key":"R27-3-20210126","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/oxfordjournals.aje.a113353","article-title":"Risk factors for epithelial ovarian cancer in Italy.","volume":"115","author":"Franceschi","year":"1982","journal-title":"Am J Epidemiol"},{"key":"R28-3-20210126","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1001\/jama.1982.03320480026020","article-title":"Epithelial ovarian cancer and combination oral contraceptives.","volume":"247","author":"Rosenberg","year":"1982","journal-title":"JAMA"},{"key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1289\/ehp.877335","article-title":"Ovarian tumors of the hen.","volume":"73","author":"Fredrickson","year":"1987","journal-title":"Environ Health Perspect"},{"key":"R31-3-20210126","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1158\/1940-6207.CAPR-08-0065","article-title":"Ovarian adenocarcinomas in the laying hen women have similar alterations in p53, ras, HER-2neu.","volume":"2","author":"Hakim","year":"2009","journal-title":"Cancer Prev Res"},{"key":"R32-3-20210126","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/00016349709050061","article-title":"The impact of parity, infertility and treatment with fertility drugs on the risk of ovarian cancer.","volume":"76","author":"Mosgaard","year":"1997","journal-title":"Acta Obstel Gynecol Scand"},{"key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1023\/A:1008960520316","article-title":"Pregnancy recency and risk of ovarian cancer.","volume":"10","author":"Cooper","year":"1999","journal-title":"Cancer Causes Control"},{"key":"R34-3-20210126","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/BF00052668","article-title":"Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study.","volume":"7","author":"Albrektsen","year":"1996","journal-title":"Cancer Causes Control"},{"key":"R35-3-20210126","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(94)90749-8","article-title":"Parity, age at first childbirth, and risk of ovarian cancer.","volume":"344","author":"Adami","year":"1994","journal-title":"Lancet"},{"key":"R36-3-20210126","first-page":"717","article-title":"Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.","volume":"71","author":"Cramer","year":"1983","journal-title":"J Natl Cancer Inst"},{"key":"R37-3-20210126","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","article-title":"Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone.","volume":"90","author":"Risch","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"R38-3-20210126","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer.","volume":"91","author":"Ness","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R39-3-20210126","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4161\/cc.8.19.9590","article-title":"Inflammation: a hidden path to breaking the spell of ovarian cancer.","volume":"8","author":"Shan","year":"2009","journal-title":"Cell Cycle"},{"key":"R40-3-20210126","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","article-title":"Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.","volume":"4","author":"Cramer","year":"2011","journal-title":"Cancer Prev Res"},{"key":"R41-3-20210126","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/oxfordjournals.aje.a115076","article-title":"Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use.","volume":"128","author":"Wu","year":"1988","journal-title":"Am J Epidemiol"},{"key":"R42-3-20210126","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/ije\/18.4.782","article-title":"Family history of ovarian cancer patients: a case-controlled study.","volume":"18","author":"Coch","year":"1989","journal-title":"Int J Epidemiol"},{"key":"R43-3-20210126","first-page":"521","article-title":"Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breastovarian cancer relationship.","volume":"4","author":"Schildkraut","year":"1989","journal-title":"Am J Human Genet"},{"key":"R44-3-20210126","first-page":"232","article-title":"Genetic analysis of breast cancer and steroid hormone study.","volume":"48","author":"Claus","year":"1991","journal-title":"Am J Hum Genet"},{"key":"R45-3-20210126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00666424","article-title":"The calculation of breast cancer risk for women with a first-degree family history of ovarian cancer.","volume":"28","author":"Claus","year":"1993","journal-title":"Breast Cancer Res Treat"},{"key":"R46-3-20210126","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/ob.1996.v175.a74288","article-title":"Role of BRCA1 mutation screening in the management of familial ovarian cancer.","volume":"175","author":"Berchuck","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R47-3-20210126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10689-005-2571-7","article-title":"Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.","volume":"5","author":"Sinilnikova","year":"2006","journal-title":"Fam Cancer"},{"key":"R48-3-20210126","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00016340500324621","article-title":"Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention.","volume":"85","author":"Sogaard","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R50-3-20210126","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/0003-4819-143-5-200509060-00012","article-title":"Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: Systematic evidence review for the U.S. Preventive Services Task Force.","volume":"143","author":"Nelson","year":"2005","journal-title":"Ann Intern Med"},{"key":"R52-3-20210126","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJMe058284","article-title":"Reducing the risk of gynecologic cancer in the Lynch syndrome.","volume":"354","author":"Offit","year":"2006","journal-title":"N Engl J Med"},{"key":"R53-3-20210126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ygyno.2010.06.003","article-title":"SGO White paper on ovarian cancer: etiology, screening and surveillance.","volume":"119","author":"Schorge","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R55-3-20210126","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/carcin\/bgq069","article-title":"BRCA1 and BRCA2: breastovarian cancer susceptibility gene products and participants in DNA double-strand break repair.","volume":"31","author":"ODonovan","year":"2010","journal-title":"Carcinogenesis"},{"key":"R56-3-20210126","first-page":"496","article-title":"Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: result from three U.S. population-based case-control studies of ovarian cancer.","volume":"60","author":"Whittemore","year":"1997","journal-title":"Am J Hum Genet"},{"key":"R57-3-20210126","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families.","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R58-3-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1098-2388(200007\/08)19:1<3::AID-SSU2>3.0.CO;2-S","article-title":"Ovarian cancer: epidemiology, biology, and prognostic factors.","volume":"19","author":"Holschneider","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"R59-3-20210126","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/ng.669","article-title":"A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population.","volume":"42","author":"Antoniou","year":"2010","journal-title":"Nat Genet"},{"key":"R60-3-20210126","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4065\/mcp.2010.0414","article-title":"Identification and management of women with BRCA mutations or hereditary predisposition for breast and ovarian cancer.","volume":"85","author":"Pruthi","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"R61-3-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10689-005-1838-3","article-title":"Gynecologic cancers in Lynch syndromeHNPCC.","volume":"4","author":"Lu","year":"2005","journal-title":"Fam Cancer"},{"key":"R62-3-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2009.01230.x","article-title":"Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications.","volume":"76","author":"Lynch","year":"2009","journal-title":"Clin Genet"},{"key":"R63-3-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome.","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R64-3-20210126","first-page":"42","article-title":"Timing of pregnancy and the risk of epithelial ovarian cancer.","volume":"12","author":"Whiteman","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R66-3-20210126","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/aje\/kwm157","article-title":"Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.","volume":"166","author":"Tworoger","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R67-3-20210126","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/aje\/kwh315","article-title":"A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs.","volume":"160","author":"Rossing","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R68-3-20210126","doi-asserted-by":"crossref","first-page":"b249","DOI":"10.1136\/bmj.b249","article-title":"Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study.","volume":"338","author":"Jensen","year":"2009","journal-title":"Br Med J"},{"key":"R69-3-20210126","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.fertnstert.2005.08.061","article-title":"Induction of ovulation and ovarian cancer: a critical review of the literature.","volume":"85","author":"Mahdavi","year":"2006","journal-title":"Fertil Steril"},{"key":"R71-3-20210126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"key":"R72-3-20210126","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.","volume":"339","author":"Narod","year":"1998","journal-title":"N Engl J Med"},{"key":"R73-3-20210126","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s10552-007-0130-2","article-title":"Breastfeeding and risk of ovarian cancer in two prospective cohorts.","volume":"18","author":"Danforth","year":"2007","journal-title":"Cancer Causes Control"},{"key":"R74-3-20210126","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10552-009-9450-8","article-title":"Breast-feeding the last born child and risk of ovarian cancer.","volume":"21","author":"Titus-Ernstoff","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R75-3-20210126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10552-009-9440-x","article-title":"Breastfeeding and risk of epithelial ovarian cancer.","volume":"21","author":"Jordan","year":"2010","journal-title":"Cancer Causes Control"},{"key":"R76-3-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-0-387-98094-2_1","article-title":"Chemoprevention of ovarian cancer.","volume":"149","author":"Hoekstra","year":"2009","journal-title":"Cancer Treat Res"},{"key":"R77-3-20210126","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1210\/er.2006-0036","article-title":"Gonadotropins and ovarian cancer.","volume":"28","author":"Choi","year":"2007","journal-title":"Endocr Rev"},{"key":"R79-3-20210126","first-page":"853","article-title":"Differential effects of N-(4-hydroxyphenyl) retinamide and retrinoic acid on neuroblastoma cells: apoptosis versus differentiation.","volume":"55","author":"Ponzoni","year":"1995","journal-title":"Can Res"},{"key":"R80-3-20210126","first-page":"6036","article-title":"N-(4-hydroxyphenyl) retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.","volume":"53","author":"Delia","year":"1993","journal-title":"Cancer Res"},{"key":"R81-3-20210126","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fasebj.10.9.8801164","article-title":"Retinoids in cancer chemoprevention.","volume":"10","author":"Lotan","year":"1996","journal-title":"FASEB J"},{"key":"R82-3-20210126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0304-3835(96)04458-8","article-title":"Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells.","volume":"110","author":"Kuo","year":"1996","journal-title":"Cancer Lett"},{"key":"R83-3-20210126","first-page":"420","article-title":"Sulfone metabolite of sulindac inhibits mammary carcinogenesis.","volume":"57","author":"Thompson","year":"1997","journal-title":"Cancer Res"},{"issue":"suppl 4","key":"R84-3-20210126","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1289\/ehp.97105s4977","article-title":"Cancer chemoprevention and therapy by monoterpenes review .","volume":"105","author":"Gould","year":"1997","journal-title":"Environ Health Perspect"},{"key":"R85-3-20210126","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/carcin\/16.2.427","article-title":"Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid.","volume":"16","author":"Pascale","year":"1995","journal-title":"Carcinogenesis"},{"key":"R87-3-20210126","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/jnci\/djh123","article-title":"Apoptosis as a novel target for cancer prevention.","volume":"96","author":"Sun","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R88-3-20210126","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/carcin\/bgi221","article-title":"NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min) mice proportionally to their tumor inhibitory effect: implications for the role of PPARdelta in carcinogenesis.","volume":"27","author":"Ouyang","year":"2006","journal-title":"Carcinogenesis"},{"key":"R89-3-20210126","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1158\/1055-9965.920.13.6","article-title":"Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.","volume":"13","author":"Sinicrope","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R90-3-20210126","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.ygyno.2005.02.030","article-title":"Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel and systemic medroxyprogesterone.","volume":"97","author":"Vereide","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R91-3-20210126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00001622-199901000-00014","article-title":"Mechanisms of apoptosis avoidance in cancer.","volume":"11","author":"Reed","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"R92-3-20210126","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/94.1.32","article-title":"Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk.","volume":"94","author":"Schildkraut","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R93-3-20210126","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","article-title":"Menopausal hormone replacement therapy and risk of ovarian cancer.","volume":"288","author":"Lacey","year":"2002","journal-title":"J Am Med Assoc"},{"key":"R94-3-20210126","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.285.11.1460","article-title":"Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.","volume":"285","author":"Rodriguez","year":"2001","journal-title":"J Am Med Assoc"},{"key":"R95-3-20210126","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0895-4356(99)00179-1","article-title":"A meta-analysis of estrogen replacement therapy and the risk of epithelial ovarian cancer.","volume":"53","author":"Coughlin","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"R96-3-20210126","first-page":"472","article-title":"Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis.","volume":"92","author":"Garg","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R97-3-20210126","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/94.7.497","article-title":"Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in 98. Swedish women.","volume":"94","author":"Riman","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R98-3-20210126","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjc.6690731","article-title":"Hormone replacement therapy and risk of epithelial ovarian cancer.","volume":"81","author":"Purdie","year":"1999","journal-title":"Br J Cancer"},{"key":"R100-3-20210126","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwh046","article-title":"Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review.","volume":"159","author":"Modugno","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R101-3-20210126","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1677\/ERC-08-0075","article-title":"Epithelial ovarian cancer: testing the androgens hypothesis.","volume":"4","author":"Olsen","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"R102-3-20210126","first-page":"5142","article-title":"Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.","volume":"9","author":"Cottreau","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R103-3-20210126","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01.AOG.0000154152.12088.48","article-title":"Androgenic progestins in oral contraceptives and the risk of epithelial ovarian cancer.","volume":"105","author":"Greer","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R105-3-20210126","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.4161\/cc.8.19.9590","article-title":"Inflammation: a hidden path to breaking the spell of ovarian cancer.","volume":"8","author":"Shan","year":"2009","journal-title":"Cell Cycle"},{"key":"R106-3-20210126","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/01.AOG.0000257126.68803.03","article-title":"C-reactive protein concentrations and subsequent ovarian cancer risk.","volume":"109","author":"McSorley","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R107-3-20210126","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/annonc\/mdq694","article-title":"Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study.","volume":"22","author":"Toriola","year":"2011","journal-title":"Ann Oncol"},{"key":"R108-3-20210126","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1158\/1055-9965.EPI-10-1180","article-title":"Circulating inflammation markers and risk of epithelial ovarian cancer.","volume":"20","author":"Clendenen","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R109-3-20210126","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0889-8545(05)70169-8","article-title":"Health benefits of oral contraceptives.","volume":"27","author":"Jensen","year":"2000","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R110-3-20210126","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(79)90860-2","article-title":"Talc in normal and malignant ovarian tissue.","volume":"1","author":"Henderson","year":"1979","journal-title":"Lancet"},{"key":"R111-3-20210126","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/1097-0142(19820715)50:2<372::AID-CNCR2820500235>3.0.CO;2-S","article-title":"Ovarian cancer and talc: a case-control study.","volume":"50","author":"Cramer","year":"1982","journal-title":"Cancer"},{"key":"R112-3-20210126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0090-8258(92)90485-2","article-title":"Mineral fiber exposure and the development of ovarian cancer.","volume":"45","author":"Rosenblatt","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R113-3-20210126","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2396::AID-CNCR15>3.0.CO;2-M","article-title":"Perineal talc exposure and risk of ovarian carcinoma.","volume":"79","author":"Chang","year":"1997","journal-title":"Cancer"},{"key":"R114-3-20210126","first-page":"19","article-title":"Perineal exposure to talc and ovarian cancer risk.","volume":"80","author":"Harlow","year":"1992","journal-title":"Obstet Gynecol"},{"key":"R115-3-20210126","first-page":"1955","article-title":"Perineal application of cosmetic talc and risk of invasive epithelial ovarian cancer: a meta-analysis of 11,933 subjects from sixteen observational studies.","volume":"23","author":"Huncharek","year":"2003","journal-title":"Anticancer Res"},{"key":"R116-3-20210126","doi-asserted-by":"crossref","first-page":"140310","DOI":"10.5402\/2011\/140310","article-title":"Endometriosis and ovarian cancer: a systematic review.","volume":"2011","author":"Sayasneh","year":"2011","journal-title":"ISRN Obstet Gynecol"},{"key":"R120-3-20210126","first-page":"447","article-title":"Pelvic inflammatory disease and the risk of epithelial ovarian cancer.","volume":"4","author":"Risch","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R121-3-20210126","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study.","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol"},{"key":"R122-3-20210126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/humupd\/dmq030","article-title":"Tubal ligation and the risk of ovarian cancer: review and meta-analysis.","volume":"17","author":"Cibula","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R123-3-20210126","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"R124-3-20210126","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/09513599709152523","article-title":"Effects of age and non-hormonal contraception on menstrual cycle characteristics.","volume":"11","author":"Dennerstein","year":"1997","journal-title":"Gynecol Endocrinol"},{"key":"R125-3-20210126","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejca.2006.11.010","article-title":"Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis.","volume":"43","author":"Olsen","year":"2007","journal-title":"Eur J Cancer"},{"key":"R126-3-20210126","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity and mortality from cancer in prospectively studied cohort of US adults.","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"R127-3-20210126","first-page":"288","article-title":"Obesity weight gain, and ovarian cancer.","volume":"100","author":"Fairfield","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R128-3-20210126","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1023\/A:1012267619561","article-title":"Body size and ovarian cancer: case-control study and systematic review.","volume":"12","author":"Purdie","year":"2001","journal-title":"Cancer Causes Control"},{"key":"R129-3-20210126","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.24086","article-title":"Body mass index and risk of ovarian cancer.","volume":"115","author":"Leitzmann","year":"2009","journal-title":"Cancer"},{"key":"R130-3-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/NCC.0b013e31819d30d6","article-title":"Epidemiologic and genetic factors associated with ovarian cancer.","volume":"32","author":"McLemore","year":"2009","journal-title":"Cancer Nursing"},{"key":"R131-3-20210126","first-page":"663","article-title":"Dietary factors and the risk of epithelial ovarian cancer.","volume":"79","author":"LaVecchia","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"R132-3-20210126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/oxfordjournals.aje.a009723","article-title":"Prospective study of diet and ovarian cancer.","volume":"149","author":"Kushi","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R133-3-20210126","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1015760004130","article-title":"Olive oil, seed oils and other added fats in relation to ovarian cancer (Italy).","volume":"13","author":"Bosetti","year":"2002","journal-title":"Cancer Causes Control"},{"key":"R134-3-20210126","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ijc.1422","article-title":"Diet and ovarian cancer risk: a case-control study in Italy.","volume":"93","author":"Bosetti","year":"2001","journal-title":"Int J Cancer"},{"key":"R135-3-20210126","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1158\/1055-9965.EPI-05-0218","article-title":"Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies.","volume":"14","author":"Koushik","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R136-3-20210126","first-page":"2531","article-title":"Fruit and vegetable consumption and risk of epithelial ovarian cancer: The European Prospective Investigation into Cancer and Nutrition.","volume":"14","author":"Schulz","year":"2005","journal-title":"Cancer Epidemiol"},{"key":"R137-3-20210126","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/ajcn\/80.5.1353","article-title":"Milk and lactose intakes and ovarian cancer risk in the Swedish mammography cohort.","volume":"80","author":"Larsson","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R138-3-20210126","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjc.6602890","article-title":"Dietary consumption and ovarian cancer risk in the Netherlands Cohort Study on Diet and cancer.","volume":"94","author":"Mommers","year":"2006","journal-title":"Br J Cancer"},{"key":"R139-3-20210126","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/01635580701733091","article-title":"Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort.","volume":"60","author":"Chang","year":"2008","journal-title":"Nutr Cancer"},{"key":"R140-3-20210126","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10552-011-9728-5","article-title":"Healthy eating index and ovarian cancer risk.","volume":"22","author":"Chandran","year":"2011","journal-title":"Cancer Causes Control"},{"key":"R141-3-20210126","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ijc.10365","article-title":"Recreational physical activity and ovarian cancer in a population-based case-control study.","volume":"99","author":"Bertone","year":"2002","journal-title":"Int J Cancer"},{"key":"R142-3-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1065>3.0.CO;2-M","article-title":"Physical activity and risk of ovarian cancer: an Italian case-control study.","volume":"91","author":"Tavani","year":"2001","journal-title":"Int J Cancer"},{"key":"R143-3-20210126","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/93.12.942","article-title":"Prospective study of recreational physical activity and ovarian cancer.","volume":"93","author":"Bertone","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R144-3-20210126","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/cncr.20146","article-title":"Anthropometric variables, physical activity, and incidence of ovarian cancer: The Iowa Womens Health Study.","volume":"100","author":"Anderson","year":"2004","journal-title":"Cancer"},{"key":"R145-3-20210126","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ijc.21157","article-title":"Physical activity and the risk of ovarian cancer: a case-control study in Canada.","volume":"117","author":"Pan","year":"2005","journal-title":"Int J Cancer"},{"key":"R147-3-20210126","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/cncr.23275","article-title":"Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer.","volume":"112","author":"Tworoger","year":"2008","journal-title":"Cancer"},{"key":"R148-3-20210126","first-page":"255","article-title":"Cigarette smoking and epithelial ovarian cancer by histologic type.","volume":"95","author":"Marchbanks","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R150-3-20210126","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.ygyno.2006.08.012","article-title":"Does smoking increase risk of ovarian cancer A systematic review.","volume":"103","author":"Jordan","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R151-3-20210126","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1024828309874","article-title":"Active and passive tobacco smoking and the risk of borderline and invasive ovarian cancer.","volume":"14","author":"Goodman","year":"2003","journal-title":"Cancer Causes Control"},{"key":"R152-3-20210126","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/humrep\/12.8.1736","article-title":"Effect of cigarette smoking and age on the maturation of human oocytes.","volume":"12","author":"Zenzes","year":"1997","journal-title":"Hum Reprod"},{"key":"R153-3-20210126","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/oxfordjournals.aje.a008939","article-title":"Predictors of ovarian steroid secretion in reproductive age women.","volume":"144","author":"Weshoff","year":"1996","journal-title":"Am J Epidemiol"},{"key":"R154-3-20210126","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJM198806303182601","article-title":"Cigarette smoking and levels of adrenal androgens in postmenopausal women.","volume":"318","author":"Khaw","year":"1988","journal-title":"N Engl J Med"},{"key":"R155-3-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0378-5122(95)00985-X","article-title":"The normal menopause transition: an overview.","volume":"23","author":"McKinlay","year":"1996","journal-title":"Maturitas"},{"key":"R156-3-20210126","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.amepre.2006.08.018","article-title":"Role of ultraviolet B irradiance and vitamin D in prevention of ovarian cancer.","volume":"31","author":"Garland","year":"2006","journal-title":"Am J Prev Med"},{"key":"R157-3-20210126","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/ije\/23.6.1133","article-title":"Sunlight, vitamin D, and ovarian cancer mortality rates in US women.","volume":"23","author":"Lefkowitz","year":"1994","journal-title":"Int J Epidemiol"},{"key":"R158-3-20210126","first-page":"2125","article-title":"The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.","volume":"86","author":"Choi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R159-3-20210126","doi-asserted-by":"crossref","first-page":"53213","DOI":"10.1074\/jbc.M410395200","article-title":"Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.","volume":"279","author":"Jiang","year":"2004","journal-title":"J Biol Chem"},{"key":"R160-3-20210126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000063814","article-title":"Nutritional determinants of epithelial ovarian cancer risk: a case-control study in Mexico.","volume":"63","author":"Salazar-Martinez","year":"2002","journal-title":"Oncology"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003081-201203000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T20:50:21Z","timestamp":1686775821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201203000-00003"}},"subtitle":["Etiology, Risk Factors, and Epidemiology"],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e31824b4611","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}